F. Grasmeijer

发表

Dry Powder Inhalation

A. D. Boer, F. Grasmeijer, 2019, Pharmaceutical Inhalation Aerosol Technology.

Dry powder inhalation: past, present and future

H. Frijlink, A. D. de Boer, P. Hagedoorn, 2017, Expert opinion on drug delivery.

University of Groningen Dry powder inhalation : past , present and future

H., P. Hagedoorn, A. D. Boer, 2017 .

University of Groningen Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG(34-56) Peptide Haanstra,

H. Frijlink, P. Hagedoorn, A. D. Boer, 2018 .

Drug Content Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation

H. Frijlink, A. D. de Boer, P. Hagedoorn, 2013, PloS one.

Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers

H. Kerstjens, M. Sturkenboom, P. Hagedoorn, 2020, medRxiv.

Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis

H. Frijlink, H. Kerstjens, D. van Soolingen, 2018, European Respiratory Journal.

In vitro evaluation of the Twincer colistin dry powder inhaler as a non-cough-inducing alternative to Colobreathe

H. Frijlink, P. Hagedoorn, A. D. Boer, 2016 .

Natural and bioinspired excipients for dry powder inhalation formulations

W. Hinrichs, H. Frijlink, F. Grasmeijer, 2021 .

Comparative in vitro performance of the new drug aclidinium in a novel multidose dry powder inhaler

H. Frijlink, P. Hagedoorn, A. D. Boer, 2013 .

Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalers

A. D. de Boer, P. Hagedoorn, F. Grasmeijer, 2022, Expert opinion on drug delivery.

A comparative analysis of changes in pMDI drug dose delivery before and after detergent coating using five antistatic valved holding chambers.

H. Frijlink, P. Hagedoorn, F. Grasmeijer, 2020, The journal of allergy and clinical immunology. In practice.

Dry powder inhalation, part 2: the present and future

A. D. de Boer, P. Hagedoorn, F. Grasmeijer, 2022, Expert opinion on drug delivery.

Aerosol drug delivery: developments in device design and clinical use

P. Hagedoorn, A. D. Boer, F. Grasmeijer, 2011, The Lancet.

New Mechanisms to Explain the Effects of Added Lactose Fines on the Dispersion Performance of Adhesive Mixtures for Inhalation

H. Frijlink, A. Hickey, A. D. de Boer, 2014, PloS one.

Characterisation of high dose aerosols from dry powder inhalers.

H. Frijlink, A. D. de Boer, P. Hagedoorn, 2012, International journal of pharmaceutics.

The pharmacokinetics of antibiotics in cystic fibrosis

H. Frijlink, G. Koppelman, D. Touw, 2020, Expert opinion on drug metabolism & toxicology.

THE INTERPLAY BETWEEN VARIABLES IN THE FORMULATION AND DISPERSION OF ADHESIVE MIXTURES FOR INHALATION

H. Frijlink, P. Hagedoorn, A. D. Boer, 2014 .

The dispersion behaviour of dry powder inhalation formulations cannot be assessed at a single inhalation flow rate.

A. D. de Boer, F. Grasmeijer, 2014, International journal of pharmaceutics.

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation

H. Frijlink, P. Hagedoorn, F. Grasmeijer, 2019, Pharmaceutics.

Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops® High Dose Dry Powder Inhalation Device While Maintaining Dispersibility

H. Frijlink, P. Hagedoorn, F. Grasmeijer, 2020, Pharmaceutics.

Recent advances in the fundamental understanding of adhesive mixtures for inhalation.

H. Frijlink, P. Hagedoorn, F. Grasmeijer, 2015, Current pharmaceutical design.

Challenges for pulmonary delivery of high powder doses

H. Frijlink, A. D. de Boer, P. Hagedoorn, 2018, International journal of pharmaceutics.

Can Patients with Parkinson’s Disease Use Dry Powder Inhalers during Off Periods?

H. Frijlink, A. D. de Boer, P. Hagedoorn, 2015, PloS one.

Colistin dry powder inhalation with the Twincer™: An effective and more patient friendly alternative to nebulization

J. Vonk, H. Frijlink, G. Koppelman, 2020, PloS one.

CARS microscopy as a tool for studying the distribution of micronised drugs in adhesive mixtures for inhalation

Herman L. Offerhaus, A. L. Fussell, H. Frijlink, 2014 .

Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or Trileucine

H. Frijlink, P. Hagedoorn, F. Grasmeijer, 2019, Pharmaceutics.

University of Groningen Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation

H. Frijlink, P. Hagedoorn, F. Grasmeijer, 2019 .

A proposed definition of the 'activity' of surface sites on lactose carriers for dry powder inhalation.

H. Frijlink, A. D. de Boer, F. Grasmeijer, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

A levodopa dry powder inhaler for the treatment of Parkinson's disease patients in off periods.

H. Frijlink, A. D. de Boer, P. Hagedoorn, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.